tolperisone has been researched along with Parkinson Disease in 2 studies
Tolperisone: A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1211)
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DOBI, S | 1 |
BLONDEL, F | 1 |
COULEON, M | 1 |
COULEON, H | 1 |
ANNE, L | 1 |
CLERC, G | 1 |
COULOMBIER, J | 1 |
2 other studies available for tolperisone and Parkinson Disease
Article | Year |
---|---|
[Mydocalm and muscle tone].
Topics: Humans; Multiple Sclerosis; Muscle Spasticity; Muscle Tonus; Paralysis; Parasympatholytics; Parkinso | 1961 |
[MYDOCALM TREATMENT OF PSEUDO-PARKINSON DISORDERS FOLLOWING THE ADMINISTRATION OF NEUROLEPTIC AGENTS].
Topics: Antipsychotic Agents; Drug Therapy; Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; P | 1964 |